Abstract
Induced pluripotent stem (iPS) cells, are a type of pluripotent stem cell derived from adult somatic cells. They have been reprogrammed through inducing genes and factors to be pluripotent. iPS cells are similar to embryonic stem (ES) cells in many aspects. This review summarizes the recent progresses in iPS cell reprogramming and iPS cell based therapy, and describe patient specific iPS cells as a disease model at length in the light of the literature. This review also analyzes and discusses the problems and considerations of iPS cell therapy in the clinical perspective for the treatment of disease.
Keywords: Cellular therapy, disease model, embryonic stem cells, induced pluripotent stem cells, reprogramm
Related Books
4D Fetal Echocardiography
Minimally Invasive Techniques for the Treatment of Patients with Structural Heart Disease
Oral Infections and Cardiovascular Disease
Cardiac Resynchronization Therapy: An Established Pacing Therapy for Heart Failure and Mechanical Dyssynchrony
MicroRNAs and Cardiovascular Disease
Preclinical Atherosclerosis, Global Cardiovascular Risk and Cardiovascular Events
New Insight in Pediatric Cardiology: From Basic to Therapeutics
Degenerative Aortic Valve Disease, its Mechanism on Progression, its Effect on the Left Ventricle and the Postoperative Results
Electrocardiography (ECG)
Latest Advances in Clinical and Pre-Clinical Cardiovascular MRI
46